The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?

P Courtet, I I Gottesman, F Jollant, T D Gould, P Courtet, I I Gottesman, F Jollant, T D Gould

Abstract

Vulnerability to suicidal behavior (SB) is likely mediated by an underlying genetic predisposition interacting with environmental and probable epigenetic factors throughout the lifespan to modify the function of neuronal circuits, thus rendering an individual more likely to engage in a suicidal act. Improving our understanding of the neuroscience underlying SBs, both attempts and completions, at all developmental stages is crucial for more effective preventive treatments and for better identification of vulnerable individuals. Recent studies have characterized SB using an endophenotype strategy, which aims to identify quantitative measures that reflect genetically influenced stable changes in brain function. In addition to aiding in the functional characterization of susceptibility genes, endophenotypic research strategies may have a wider impact in determining vulnerability to SB, as well as the translation of human findings to animal models, and vice versa. Endophenotypes associated with vulnerability to SB include impulsive/aggressive personality traits and disadvantageous decision making. Deficits in realistic risk evaluation represent key processes in vulnerability to SB. Serotonin dysfunction, indicated by neuroendocrine responses and neuroimaging, is also strongly implicated as a potential endophenotype and is linked with impulsive aggression and disadvantageous decision making. Specific endophenotypes may represent heritable markers for the identification of vulnerable patients and may be relevant targets for successful suicide prevention and treatments.

Keywords: animal models; biomarker; decision making; emotions; orbitofrontal cortex; suicide.

Figures

Figure 1
Figure 1
Candidate gene regions, genes and endophenotypes implicated in suicide research. The upper portion of the figure indicates the dynamic interplay among genetic, epigenetic and environmental factors that produce cumulative liability to suicidal behaviors. Although attempted suicide does not always predate a completed suicide as suggested on the reaction surface, it is a significant risk factor. None of the sections of this figure can be definitive; many more gene loci, genes, candidate endophenotypes and links among the three remain to be discovered. Environment, protective and harmful, includes a substantial number of environmental events (for example, drug exposure) unmentioned here because of our focus on genetic and neurobiological correlates. Similarly, there are many gene loci, genes and candidate endophenotypes that were not included because of the conceptual limitations of this Figure. Modified from Kovacsics et al. See the following reviews for additional discussion: refs , , , , , , , . © II Gottesman and TD Gould and used with permission.

References

    1. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA. 2005;293:2487–2495.
    1. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, et al. Suicidality and risk of suicide—definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010;71:e1–e21.
    1. Linehan MM. Suicidal people. One population or two. Ann NY Acad Sci. 1986;487:16–33.
    1. Cheng AT, Chen TH, Chen CC, Jenkins R. Psychosocial and psychiatric risk factors for suicide. Case-control psychological autopsy study. Br J Psychiatry. 2000;177:360–365.
    1. Roy A, Rylander G, Sarchiapone M. Genetics of suicides. Family studies and molecular genetics. Ann NY Acad Sci. 1997;836:135–157.
    1. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry. 1996;53:1145–1152.
    1. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4:819–828.
    1. Mann JJ. Psychobiologic predictors of suicide. J Clin Psychiatry. 1987;48 (Suppl:39–43.
    1. Labonte B, Turecki G. The epigenetics of suicide: explaining the biological effects of early life environmental adversity. Arch Suicide Res. 2010;14:291–310.
    1. Mann JJ, Currier DM. Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression. Eur Psychiatry. 2010;25:268–271.
    1. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology. 2001;24:467–477.
    1. Baud P. Personality traits as intermediary phenotypes in suicidal behavior: genetic issues. Am J Med Genet. 2005;133:34–42.
    1. Brezo J, Paris J, Turecki G. Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr Scand. 2006;113:180–206.
    1. Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry. 2009;65:556–563.
    1. Courtet P, Guillaume S, Malafosse A, Jollant F. Genes, suicide and decisions. Eur Psychiatry. 2010;25:294–296.
    1. Gottesman II, Shields J. Schizophrenia and Genetics; A Twin Study Vantage Point. Academic Press Inc.: New York; 1972.
    1. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645.
    1. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry. 2010;15:789–797.
    1. Siever LJ. Endophenotypes in the personality disorders. Dialogues Clin Neurosci. 2005;7:139–151.
    1. Insel TR, Cuthbert BN. Endophenotypes: bridging genomic complexity and disorder heterogeneity. Biol Psychiatry. 2009;66:988–989.
    1. Leboyer M, Slama F, Siever L, Bellivier F. Suicidal disorders: a nosological entity per se. Am J Med Genet. 2005;133C:3–7.
    1. Rosen A. Detection of suicidal patients: an example of some limitations in the prediction of infrequent events. J Consult Psychol. 1954;18:397–403.
    1. Meehl PE, Rosen A. Antecedent probability and the efficiency of psychometric signs, patterns, or cutting scores. Psychol Bull. 1955;52:194–216.
    1. Roy A, Segal NL, Centerwall BS, Robinette CD. Suicide in twins. Arch Gen Psychiatry. 1991;48:29–32.
    1. Brent DA, Melhem N. Familial transmission of suicidal behavior. Psychiatr Clin North Am. 2008;31:157–177.
    1. Wasserman D, Terenius L, Wasserman J, Sokolowski M. The 2009 Nobel conference on the role of genetics in promoting suicide prevention and the mental health of the population. Mol Psychiatry. 2010;15:12–17.
    1. Jollant F, Lawrence NL, Olie E, Guillaume S, Courtet P.The suicidal mind and brain: a review of neuropsychological and neuroimaging studies World J Biol Pschiatry 2011(e-pub ahead of print).
    1. Kovacsics CE, Gottesman II, Gould TD. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Ann Rev Pharmacol Toxicol. 2009;49:175–198.
    1. Grunebaum MF, Ramsay SR, Galfalvy HC, Ellis SP, Burke AK, Sher L, et al. Correlates of suicide attempt history in bipolar disorder: a stress-diathesis perspective. Bipolar Disord. 2006;8 (5 Part 2:551–557.
    1. Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF, Burke A, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161:1433–1441.
    1. Caspi A, Moffitt TE, Newman DL, Silva PA. Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. Arch Gen Psychiatry. 1996;53:1033–1039.
    1. Melhem NM, Brent DA, Ziegler M, Iyengar S, Kolko D, Oquendo M, et al. Familial pathways to early-onset suicidal behavior: familial and individual antecedents of suicidal behavior. Am J Psychiatry. 2007;164:1364–1370.
    1. Brent DA, Oquendo M, Birmaher B, Greenhill L, Kolko D, Stanley B, et al. Peripubertal suicide attempts in offspring of suicide attempters with siblings concordant for suicidal behavior. Am J Psychiatry. 2003;160:1486–1493.
    1. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci. 2005;30:398–408.
    1. Vaidyanathan U, Patrick CJ, Cuthbert BN. Linking dimensional models of internalizing psychopathology to neurobiological systems: affect-modulated startle as an indicator of fear and distress disorders and affiliated traits. Psychol Bull. 2009;135:909–942.
    1. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15.
    1. Jollant F, Bellivier F, Leboyer M, Astruc B, Torres S, Verdier R, et al. Impaired decision making in suicide attempters. Am J Psychiatry. 2005;162:304–310.
    1. Jollant F, Lawrence NS, Olie E, O'Daly O, Malafosse A, Courtet P, et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage. 2010;51:1275–1281.
    1. Malloy-Diniz LF, Neves FS, Abrantes SS, Fuentes D, Correa H. Suicide behavior and neuropsychological assessment of type I bipolar patients. J Affect Disord. 2009;112:231–236.
    1. Martino DJ, Strejilevich SA, Torralva T, Manes F. Decision making in euthymic bipolar I and bipolar II disorders. Psychol Med. 2010. pp. 1–9.
    1. Oldershaw A, Grima E, Jollant F, Richards C, Simic M, Taylor L, et al. Decision making and problem solving in adolescents who deliberately self-harm. Psychol Med. 2009;39:95–104.
    1. Dombrovski AY, Clark L, Siegle GJ, Butters MA, Ichikawa N, Sahakian BJ, et al. Reward/punishment reversal learning in older suicide attempters. Am J Psychiatry. 2010;167:699–707.
    1. Lovallo WR, Yechiam E, Sorocco KH, Vincent AS, Collins FL. Working memory and decision-making biases in young adults with a family history of alcoholism: studies from the Oklahoma family health patterns project. Alcohol Clin Exp Res. 2006;30:763–773.
    1. Jollant F, Buresi C, Guillaume S, Jaussent I, Bellivier F, Leboyer M, et al. The influence of four serotonin-related genes on decision-making in suicide attempters. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:615–624.
    1. da Rocha FF, Malloy-Diniz L, Lage NV, Romano-Silva MA, de Marco LA, Correa H. Decision-making impairment is related to serotonin transporter promoter polymorphism in a sample of patients with obsessive-compulsive disorder. Behav Brain Res. 2008;195:159–163.
    1. Stoltenberg SF, Vandever JM. Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk. Neuropharmacology. 2010;58:423–428.
    1. Thorell LH. Valid electrodermal hyporeactivity for depressive suicidal propensity offers links to cognitive theory. Acta Psychiatr Scand. 2009;119:338–349.
    1. Critchley HD, Elliott R, Mathias CJ, Dolan RJ. Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci. 2000;20:3033–3040.
    1. Lykken DT, Iacono WG, Haroian K, McGue M, Bouchard TJ., Jr Habituation of the skin conductance response to strong stimuli: a twin study. Psychophysiology. 1988;25:4–15.
    1. Storrie MC, Doerr HO, Johnson MH. Skin conductance characteristics of depressed subjects before and after therapeutic intervention. J Nerv Ment Dis. 1981;169:176–179.
    1. Guillaume S, Jollant F, Jaussent I, Lawrence N, Malafosse A, Courtet P. Somatic markers and explicit knowledge are both involved in decision-making. Neuropsychologia. 2009;47:2120–2124.
    1. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry. 2000;57:729–738.
    1. Monkul ES, Hatch JP, Nicoletti MA, Spence S, Brambilla P, Lacerda AL, et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry. 2007;12:360–366.
    1. Aguilar EJ, Garcia-Marti G, Marti-Bonmati L, Lull JJ, Moratal D, Escarti MJ, et al. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1673–1676.
    1. Wagner G, Koch K, Schachtzabel C, Schultz CC, Sauer H, Schlosser RG. Structural brain alterations in patients with major depressive disorder and high risk for suicide: evidence for a distinct neurobiological entity. Neuroimage. 2011;54:1607–1614.
    1. van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Dis. 2003;74:149–158.
    1. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry. 2006;60:207–217.
    1. Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S, et al. Brain regional alpha-[11C]methyl--tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry. 2001;158:775–782.
    1. Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, et al. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry. 2008;165:740–748.
    1. Jollant F, Lawrence NS, Olie E, O'Daly O, Malafosse A, Courtet P, et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage. 2010;51:1275–1281.
    1. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 2003;60:14–22.
    1. Correa H, Duval F, Mokrani M, Bailey P, Tremeau F, Staner L, et al. Prolactin response to -fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 2000;93:189–199.
    1. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry. 1996;168:324–329.
    1. Jollant F, Lawrence NL, Olie E, Guillaume S, Courtet P.The suicidal mind and brain: a review of neuropsychological and neuroimaging studies World J Biol Psychiatry 2011(in press).
    1. Rao H, Gillihan SJ, Wang J, Korczykowski M, Sankoorikal GM, Kaercher KA, et al. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiatry. 2007;62:600–606.
    1. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage. 2002;17:317–323.
    1. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci. 2005;8:20–21.
    1. Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav. 2006;5:113–119.
    1. Olie E, Guillaume S, Jaussent I, Courtet P, Jollant F. Higher psychological pain during a major depressive episode may be a factor of vulnerability to suicidal ideation and act. J Affect Disord. 2010;120:226–230.
    1. Geyer MA, Markou A.Animal models of psychiatric disordersIn: Bloom FE, Kupfer DJ (eds).Psychopharmacology: the Fourth Generation of Progress Raven Press: New York; 1995787–798.
    1. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984;83:1–16.
    1. McKinney WT. Animal models of depression: an overview. Psychiatr Dev. 1984;2:77–96.
    1. Preti A.Animal model and neurobiology of suicide Prog Neuropsychopharmacol Biol Psychiatry 2011(e-pub ahead of print).
    1. Malkesman O, Pine DS, Tragon T, Austin DR, Henter ID, Chen G, et al. Animal models of suicide-trait-related behaviors. Trends Pharmacol Sci. 2009;30:165–173.
    1. van den Bos R, Lasthuis W, den Heijer E, van der Harst J, Spruijt B. Toward a rodent model of the Iowa gambling task. Behav Res Methods. 2006;38:470–478.
    1. Rivalan M, Ahmed SH, Dellu-Hagedorn F. Risk-prone individuals prefer the wrong options on a rat version of the Iowa Gambling Task. Biol Psychiatry. 2009;66:743–749.
    1. Homberg JR, van den Bos R, den Heijer E, Suer R, Cuppen E. Serotonin transporter dosage modulates long-term decision-making in rat and human. Neuropharmacology. 2008;55:80–84.
    1. Pais-Vieira M, Mendes-Pinto MM, Lima D, Galhardo V. Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain. Neuroscience. 2009;161:671–679.
    1. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467–1473.
    1. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8 (5 Part 2:625–639.
    1. Muller-Oerlinghausen B. Arguments for the specificity of the antisuicidal effect of lithium. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 2:II72–II75.
    1. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord. 2007;107:23–28.
    1. Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, et al. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 2008;58:37–47.
    1. Kovacsics CE, Gould TD. Shock-induced aggression in mice is modified by lithium. Pharmacol Biochem Behav. 2010;94:380–386.
    1. Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med. 2007;37:163–180.
    1. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol. 2006;2:267–290.
    1. Walters JT, Owen MJ. Endophenotypes in psychiatric genetics. Mol Psychiatry. 2007;12:886–890.
    1. Bullmore E, Barnes A, Bassett DS, Fornito A, Kitzbichler M, Meunier D, et al. Generic aspects of complexity in brain imaging data and other biological systems. Neuroimage. 2009;47:1125–1134.
    1. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010;34:1161–1177.
    1. Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, Hohmann M, et al. Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J Neurosci. 2006;26:6469–6472.
    1. Schutter DJ, van Honk J. Increased positive emotional memory after repetitive transcranial magnetic stimulation over the orbitofrontal cortex. J Psychiatry Neurosci. 2006;31:101–104.
    1. van Honk J, Schutter DJ, d'Alfonso A, Kessels RP, Postma A, de Haan EH. Repetitive transcranial magnetic stimulation at the frontopolar cortex reduces skin conductance but not heart rate: reduced gray matter excitability in orbitofrontal regions. Arch Gen Psychiatry. 2001;58:973–974.
    1. Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N, et al. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry. 2003;64:951–953.
    1. Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction. 2010;105:49–55.
    1. Camprodon JA, Martinez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 2007;86:91–94.
    1. Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am. 2008;31:247–269.
    1. Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry. 2006;11:336–351.
    1. Brezo J, Klempan T, Turecki G. The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am. 2008;31:179–203.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever